Penn Pharma appoints Jerome Detreille senior director
This article was originally published in Scrip
Specialist provider of pharmaceutical development and manufacturing services Penn Pharma has named Jerome Detreille to its executive team as senior director of new business development. Penn recently invested £14 million in a new South Wales, UK facility, and Mr Detreille's role will be integral to the success of the 15,000 sq ft development and commercial manufacturing unit which will open in January 2013. He joins Penn from Catalent Pharma Solutions where he headed up a European sales and business development team.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.